The challenge of diagnosing atheroembolic renal disease: Clinical features and prognostic factors

Circulation

Volumn 116, Issue 3, 2007, Pages 298-304

  Scolari, Francesco ^a,i   Ravani, Pietro ^b,c   Gaggi, Rossella ^d   Santostefano, Marisa ^e   Rollino, Cristiana ^f   Stabellini, Nevio ^g   Colla, Loredana ^h   Viola, Battista Fabio ^a   Maiorca, Paolo ^a   Venturelli, Chiara ^a   Bonardelli, Stefano ^a   Faggiano, Pompilio ^a   Barrett, Brendan J ^b  

^a SPEDALI CIVILI   (Italy)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c Division of Nephrology and Dialysis   (Italy)

^d Malpighi Hospital   (Italy)

^e Ospedale Civile   (Italy)

^f S GIOVANNI BOSCO HOSPITAL   (Italy)

^g Ospedale Civile   (Italy)

^h MOLINETTE HOSPITAL   (Italy)

ⁱ 1 Spedali Civili   (Italy)

Author keywords

Anticoagulants; Atherosclerosis; Catheterization; Cholesterol; Diabetes mellitus; Fibrillation; Peripheral vascular disease

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; ATHEROEMBOLIC RENAL DISEASE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMBOLISM; FEMALE; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; EMBOLISM, CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 34547569416     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.680991     Document Type: Article

References (21)

1. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987;42:769-784.
2. Thadhani R, Camargo C, Xavier R, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: natural history based on 52 biopsy-proven cases. Medicine. 1995;74:350-358.
3. Mayo R, Swartz R. Redefining the incidence of clinically detectable atheroembolism. Am J Med. 1996;100:524-529.
4. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis. 1999;33:840-850.
5. Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi S, Zorat S, Bonardelli S, Tardanico R, Maiorca R. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996;11:1607-1612.
6. Scolari F, Tardanico R, Zani R, Pola A, Viola B, Movilli E, Maiorca R. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis. 2000;36:1089-1109.
7. Zuccala A, Zucchelli P. A renal disease frequently found postmortem, but rarely diagnosed in vivo. Nephrol Dial Transplant. 1997;12:1762-1767.
8. Scolari F, Ravani P, Pola P, Guerini S, Zubani R, Movilli E, Savoldi S, Malberti F, Maiorca R. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. 2003;14:1584-1590.
9. Polu K, Wolf M. Needle in a haystack. N Engl J Med. 2006;354:68-73.
10. Levey A, Greene T, Kusek J; Modification of Diet in Renal Disease Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828.
11. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39:S46-S75.
12. Wei L, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc. 1989;84:1065-1073.
13. Therneau T, Grambisch P. Multiple events per subject and frailty models. In: Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000:159-260.
14. Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
15. Scoble J, O'Donnell P. Renal atheroembolic disease: the Cinderella of nephrology. Nephrol Dial Transplant. 1996;11:1516-1517.
16. Falanga V, Fine M, Kapoor W. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. 1986;122:1194-1198.
17. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int. 2006;69:1308-1312.
18. Schiele F, Meneveau N, Seronde MF, Caufield F, Fouche R, Lassabe G, Baborier D, Legalery P, Bassand JP; the Reseau de Cardiologie de Franche Comte Groupe. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J. 2005;26:873-880.
19. Conte F. Italian Registry of Dialysis and Transplantation. Available at http://www.sin-ridt.org.htm. Accessed October 9, 2006.
20. Pitt B, Waters D, Brown W, van Boven A, Schwartz L, Tittle L, Eisenberg D, Shurzinske L, McCormick L. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med. 1999;341:70-76.
21. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercury M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high resolution noninvasive magnetic resonance imaging. Circulation. 2002;106:2884-2887.